The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Bromelain’s activity and potential as an anti-cancer agent: Current evidence and perspectives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 2×
“The leading viewpoint suggests that control of chronic inflammation could reduce the incidence of cancer as well as inhibit cancer progression [26].”
BackgroundMassagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Signal transduction of inflammatory cytokines and tumor development
Yoshimura, A. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00197.x · Cited by 314
RAGE and RAGE ligands in cancer
Logsdon, C., Fuentes, M., Huang, E., & Arumugam, T. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220697 · Cited by 209 · cited 1×
“Tumors and cells in the tumor micro-environment were found to express RAGE ligands that stimulate proliferation, invasion, chemoresistance and metastasis of cancer cells [46].”
BackgroundDesser, L., Rehberger, A., & Paukovits, W. (1994) · Cancer Biotherapy · doi:10.1089/cbr.1994.9.253 · Cited by 45
Cited by
Properties and Therapeutic Application of Bromelain: A Review
Pavan, R., Jain, S., Shraddha, & Kumar, A. (2012) · Biotechnology Research International · doi:10.1155/2012/976203 · Cited by 484
Potential role of bromelain in clinical and therapeutic applications
Rathnavelu, V., Alitheen, N. B., Sohila, S., Kanagesan, S., & Ramesh, R. (2016) · Biomedical Reports · doi:10.3892/br.2016.720 · Cited by 261
Metadata
- Authors
- Chobotova, K., Vernallis, A. B., & Majid, F. A. A.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 290
- Issue
- 2
- Pages
- 148-156
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2158670585
- Cited by
- 209
- References
- 6
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.